Chief Commercial Officer Hopman Mark was granted 109,105 shares and sold $10,310 worth of shares (834 units at $12.36), increasing direct ownership by 347% to 139,486 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

BBNX· Beta Bionics Inc.

Health Care

Original source

Chief Commercial Officer Hopman Mark was granted 109,105 shares and sold $10,310 worth of shares (834 units at $12.36), increasing direct ownership by 347% to 139,486 units (SEC Form 4) | Quantisnow